Publication protocol
YAMC cells were maintained under permissive growth conditions in DMEM medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 50 μg/ml gentamicin, 100 U/ml penicillin, 100 μg/ml streptomycin, and 5 U/ml IFN-γ in a humidified incubator with 5% CO2 at 33°C [24, 43]. These cells were plated in 96-well plates at 33°C for 20 h and hexadimethrine bromide (8 μg/ml) was added to the cells to enhance transduction efficiency. Lentiviral particles containing Slc7a2 or control shRNAs (Sigma) were added at an MOI of 5 and incubated for an additional 20 h at 33°C. Transduced cells were selected in complete medium with 10 μg/ml puromycin, which was replaced every 3–4 days for 3 weeks [24]. YAMC cells, transduced or not, were then transferred at 37°C in IFN-γ-free medium for 24 h before infection with C. rodentium.
Caco-2 and HEK 293T cells were grown in DMEM containing 10% fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. These cells were plated at 5 X 105 cells per well in 6-well plates at 37°C for 20 h. Medium was changed to Opti-MEM I Reduced-Serum Media (Invitrogen) and cells were transfected using Lipofectamine 2000 (Life Technologies) with i) 100 nM ON-TARGETplus siRNAs (Dharmacon) directed against human SLC7A2 or scrambled siRNAs, or ii) 1 μg of the pLX304 plasmid vector expressing or not the human SLC7A2 gene. After 6 h, cells were washed, maintained 24–48 h in fresh medium, and then infected with C. rodentium or EPEC, in the presence or absence of 40 mM L-Lys
Full paper
Login or
join for free to view the full paper.
Videos
Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - HEK293 SLC7A2 using ON-TARGETplus Human SLC7A2 (6542) siRNA - SMARTpool from Dharmacon. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.